Stapgen

Early Stage

We aim to prevent T2DM prior to the rise of blood sugar.

Overview

Raised to Date: Raised: $0

Total Commitments ($USD)

Platform

Wefunder

Start Date

11/15/2022

Close Date

12/17/2022

Min. Goal

$50,000

Max. Goal

$85,000

Min. Investment

$100

Security Type

SAFE

Series

Seed

SEC Filing Type

RegCF    Open SEC Filing

Valuation Cap

$20,000,000

Discount

0%

Rolling Commitments ($USD)

Status
Not Funded
Reporting Date

12/18/2022

Days Remaining
Not Funded
% of Min. Goal

0%

% of Max. Goal

0%

Likelihood of Max
Not Funded
Avg. Daily Raise

$0

Momentum
Not Funded
Create a free account today to gain access to KingsCrowd analytics.
Year Founded

2022

Industry

Healthcare & Pharmaceuticals

Tech Sector

HealthTech

Distribution Model

B2B

Margin

Medium

Capital Intensity

High

Location

Reading, Massachusetts

Business Type

Growth

Stapgen, with a valuation of $20 million, is raising funds on Wefunder. The company has developed its patented STAP-Test, used as the preventive test for Type 2 diabetes. The test will be used to detect the risk of Type 2 diabetes in advance, even before the rise of blood sugar, so that the disease can be intercepted. Stapgen is led by an experienced team and has granted a patent for the US with patents pending in other countries. Biplab K. Malo founded Stapgen in February 2022. The current crowdfunding campaign has a minimum target of $50,000 and a maximum target of $85,000. The campaign proceeds will be used for product development, lab rental, and product promotion.

Summary Profit and Loss Statement

Most Recent Year Prior Year

Revenue

$0

$0

COGS

$0

$0

Tax

$0

$0

 

 

Net Income

$0

$0

Summary Balance Sheet

Most Recent Year Prior Year

Cash

$0

$0

Accounts Receivable

$0

$0

Total Assets

$0

$0

Short-Term Debt

$0

$0

Long-Term Debt

$0

$0

Total Liabilities

$0

$0

Financials as of: 11/15/2022
Create a free account today to gain access to KingsCrowd analytics.

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Edge

$12.42 /month
billed annually
Free portfolio tracking and KingsCrowd's quantitative ratings on all raises.
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings (excluding risk)
Advanced company search ( with ratings)
Markets page filters and historical industry data
Get Edge Annual

Edge Pro

$41.58 /month
billed annually
Full site access including KingsCrowd's qualitative analyst reports.
Plan Includes:
Everything in Edge, plus
Full access to detailed Analyst Reports (e.g. Top Deal, Deal to Watch, Neutral, and Underweight)
Search and filter based on Analyst Reports
In-depth risk ratings for every raise
Get Edge Pro Annual
Already a member? Log in here.

Ratings KingsCrowd Startup Rating Methodology Article

Are you the founder of Stapgen? Create your account today to claim this raise page.

Create your first portfolio

Create your very own investment portfolio on KingsCrowd.

Now you can track all of your startup investments in one place utilizing our state-of-the-art portfolio tracker tools. To begin, create your first portfolio below.

Add to portfolio
Stapgen on Wefunder 2022
Platform: Wefunder
Security Type: SAFE
Valuation: $20,000,000

Follow company

Follow Stapgen on Wefunder 2022
Withdrawn